Original article / research
Year :
2025 |
Month :
April
|
Volume :
14 |
Issue :
2 |
Page :
BO01 - BO06 |
Full Version
|
|
Correlation between Postdialysis Serum Magnesium Levels and Atherosclerosis Risk among Chronic Kidney Disease Patients: A Cross-sectional Study
|
M Suresh, Dhivya Manickam, N Monika, Madhav Venkatesan, K Venkatesh, Ishwarya Annamalai, P Sabari Arasu 1. Lab Technician, Department of Biochemistry, A.S. Hospital, Ariyalur, Tamil Nadu, India.
2. Associate Professor, Department of Biochemistry, KMCH IHSR, Coimbatore, Tamil Nadu, India.
3. Assistant Professor, Department of Biochemistry, KMCH IHSR, Coimbatore, Tamil Nadu, India.
4. Consultant Nephrologist, Department of Nephrology, KMCH, Coimbatore, Tamil Nadu, India.
5. Consultant Radiologist, Department of Radiology, KMCH, Coimbatore, Tamil Nadu, India.
6. Consultant Nephrologist, Department of Nephrology, KMCH IHSR, Coimbatore, Tamil Nadu, India.
7. Associate Professor, Department of Radiology, KMCH IHSR, Coimbatore, Tamil Nadu, India.
|
|
Correspondence
Address :
M Suresh, Dhivya Manickam, N Monika, Madhav Venkatesan, K Venkatesh, Ishwarya Annamalai, P Sabari Arasu, Dr. N Monika,
Assistant Professor, Department of Biochemistry, KMCH IHSR,
Coimbatore-641014, Tamil Nadu, India.
E-mail: monikarajan57@gmail.com
|
| ABSTRACT |  | : Introduction: Chronic Kidney Disease (CKD) patients undergoing haemodialysis are more prone for hypomagnesemia. A lack of magnesium can hasten the development of atherosclerosis and vascular calcification. The most widely used non invasive marker for assessing atherosclerosis risk is the measurement of Carotid Intima-Media Thickness (CIMT). The role of magnesium in cardiovascular health can be assessed by correlating serum magnesium levels with CIMT.
Aim: To correlate postdialysis serum magnesium levels and atherosclerosis risk as measured by ultrasound-guided CIMT in CKD patients undergoing Maintenance Haemodialysis (MHD).
Materials and Methods: A hospital-based cross-sectional study was conducted at KMCH Institute of Health Sciences and Research, Coimbatore, Tamil Nadu, India from May 2023 to July 2023. The study included 100 CKD patients undergoing MHD. Postdialysis, serum magnesium levels and CIMT were measured. Relevant laboratory investigations and clinical history were taken from the case records. Analysis of variance and Student’s t-test were employed for the statistical analysis of the data. The correlation between the parameters was assessed using Pearson’s correlation coefficient.
Results: The mean magnesium level was 1.5±0.3 mg/dL, 36% of the study population had hypomagnesemia. The mean right-side and left-side CIMT in the study population were 0.56 mm and 0.6 mm, respectively. There was a negative correlation between CIMT and magnesium (Right CIMT r-value=-0.046, p-value=0.651; Left CIMT r-value=-0.066, p-value=0.512), but it was not statistically significant. CIMT showed a significant negative correlation with serum creatinine (Right CIMT r-value=-0.220, p-value=0.029; Left CIMT r-value=-0.126, p-value=0.216) and serum phosphate (Right CIMT r-value=-0.256, p-value=0.017; Left CIMT r-value=-0.233, p-value=0.030). CIMT showed a significant correlation between with duration of hypertension (Right CIMT r-value=0.299, p-value=0.003; Left CIMT r-value=0.232, p-value=0.020) and dialysis (Right CIMT r-value=0.288, p=0.004; Left CIMT r-value=0.204, p-value=0.041).
Conclusion: There was a negative correlation between CIMT and serum magnesium levels, but it was not statistically significant. Thus, decreased serum magnesium levels may be an additional risk factor, along with disordered homeostasis of calcium, phosphorous, duration of dialysis, diabetes and hypertension, for developing adverse cardiovascular events. |
 |
Keywords
: Carotid intima media thickness, Estimated glomerular filtration rate, Renal disorder, Renal replacement therapy |
|
DOI and Others
: DOI: 10.7860/NJLM/2025/75980.2903
Date of Submission: Oct 04, 2024
Date of Peer Review: Dec 31, 2024
Date of Acceptance: Feb 10, 2025
Date of Publishing: Apr 01, 2025
AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA
PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Oct 05, 2024
• Manual Googling: Jan 18, 2025
• iThenticate Software: Feb 08, 2025 (13%)
ETYMOLOGY: Author Origin
EMENDATIONS: 7 |
|
|
TABLES AND FIGURES |  |
|
|
|
 |
|